CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
LF-rTMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06064734
NCT06064734N/ACompleted
CompareCT.gov

Low-Frequency REpetitive TRanscranial Magnetic Stimulation in ACute Ischemic StrokE Within 48 Hours (RETRACE-I): A Randomized, Open-label, Evaluator-blinded, Phase 2 Pilot Trial

Beijing Tiantan Hospital·interventional·Posted Oct 3, 2023·Updated Apr 15, 2026

In Brief

A clinical study evaluating LF-rTMS for Stroke, Acute and Stroke, Ischemic. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This is a multicenter, open-label, evaluator-blinded, investigator-initiated, randomized clinical trial, to evaluate the clinical efficacy and safety of LF-rTMS in reducing infarct size, reducing disability rate and improving functional outcome in patients with acute ischemic stroke within 48 hours after stroke onset.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Acute, Stroke, Ischemic
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedOct 3, 2023
Enrollment StartMar 11, 2024
Primary CompletionJul 28, 2025
Study CompletionOct 25, 2025
TodayJul 1, 2026
Enrollment to primary: 1.4 yearsPosted 2.7 years ago

Interventions

LF-rTMSdevice

H 4 Coil (stimulation site: prefrontal cortex, insular lobe),1-Hz rTMS, stimulation intensity RMT 100%,1200 pulses/session, two sessions (2400 pulses)/day (interval ≥2 hours), lasting about half an hour each time, the total duration of treatment was 3 days (6 sessions,7200 pulses).